Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.
Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and ex
06/05/2026
ASCO 2026 showcased remarkable advances across oncology, but several broader trends stood out beyond the individual study results.
In this article, Cromos Pharma CEO Vlad Bogin, MD, FACP shares five developments that he believes could have the greatest impact on the future of cancer research and clinical development.
Read the article: https://cromospharma.com/asco-2026-five-trends-that-caught-my-attention/
06/01/2026
Greetings from ASCO 2026.
Cromos Pharma's CEO, Vlad Bogin, MD, FACP, is on the ground in Chicago, joining discussions with sponsors, investigators, and industry leaders from around the world.
ASCO is always a great reminder of what makes this industry so special: brilliant minds, groundbreaking science, and a shared commitment to improving the lives of patients.
05/28/2026
AI is no longer viewed simply as a tool for operational efficiency in clinical trials.
The FDA is increasingly positioning AI as part of the clinical development infrastructure itself, with growing focus on governance, oversight, transparency, and regulatory trust.
In this article, we explore what the FDA’s recent initiatives could mean for the future of clinical research and why the industry may be entering a new phase of AI adoption.
Read more: https://cromospharma.com/fda-ai-and-the-future-of-clinical-trials/
05/27/2026
Poland is no longer just a cost-driven clinical research destination.
With strong oncology patient access, experienced investigators, growing infrastructure, and increasing operational maturity, the country is becoming a strategic market for European oncology trials.
In this article, Magda Klosowska, Regional Clinical Manager for Europe at Cromos Pharma, shares why sponsors should rethink Poland’s role in oncology clinical development.
Read more: https://cromospharma.com/cro-in-poland-why-poland-is-becoming-a-core-country-for-oncology-clinical-trials-in-europe/
We’re pleased to share that Nicole Brenna, US Business Development Director at Cromos Pharma, will be attending the BIO International Convention 2026, taking place June 22–25 in San Diego, CA.
BIO is one of the leading global biotechnology events, bringing together professionals across biotech, pharma, clinical research, and healthcare innovation. The convention offers valuable opportunities for networking, partnership development, and discussions on the future of life sciences.
Nicole is looking forward to meeting with industry colleagues and discussing how Cromos Pharma supports global clinical development programs across a wide range of therapeutic areas.
If you will be attending BIO 2026 and would like to connect, please contact us at [email protected]
As Memorial Day weekend begins, Cromos Pharma takes a moment to honor and remember the brave men and women who gave their lives in service to their country.
We sincerely thank them for their sacrifice, courage, and dedication. Wishing everyone a safe and meaningful holiday weekend.
We’re pleased to share that Vlad Bogin, MD, FACP will be attending the 2026 ASCO Annual Meeting, taking place May 29 – June 2, in Chicago, IL.
ASCO remains one of the leading global oncology events, bringing together experts across clinical research and healthcare to discuss the latest scientific advances, innovative therapies, and the future of cancer care. The meeting also provides a valuable opportunity to exchange insights on oncology clinical development and evolving clinical trial strategies.
Vlad is looking forward to meeting with industry colleagues and discussing how Cromos Pharma can support oncology clinical development programs worldwide.
If you will be attending ASCO and would like to connect, please contact us at [email protected]
05/20/2026
On World Clinical Trials Day, the conversation is no longer only about innovation.
As clinical trials become more complex across operations, technology, patient recruitment, and site management, the industry is facing a new challenge: not just developing therapies, but delivering trials efficiently at scale.
In our latest article, we explore the key trends shaping clinical research in 2026. Read more: https://cromospharma.com/world-clinical-trials-day-clinical-research-is-not-where-it-used-to-be/?preview_id=11753&preview_nonce=c21d76b9e3&_thumbnail_id=11754&preview=true
Cromos Pharma is currently seeking an Associate HR Operations Specialist to join our team.
Location: Europe
For additional details about this opportunity, please visit our website: https://cromospharma.com/associate-hr-operations-manager/
If you're ready to apply, please send your CV to [email protected]
05/12/2026
The recent US–UK pharmaceutical agreement may be about far more than drug pricing.
Pharma is increasingly becoming part of trade strategy, industrial policy, and geopolitical competition. As global powers compete for innovation, investment, and manufacturing leadership, the rules shaping the industry may be changing faster than many realize.
Read more:https://cromospharma.com/the-us-uk-pharma-deal-is-bigger-than-it-looks/